Table of Contents

• CVM Names Two to Senior Posts [ARCHIVED]
  by Joanne M. Kla
• A Contemporary Approach to Risk Analysis in GFI #152 [ARCHIVED]
  by H. Gregg Claycamp, Ph.D.
• Leveraging Examples - Part III: CRADAS [ARCHIVED]
  by Marilyn Martinez, Ph.D.
• Concluding Comments [ARCHIVED]
• CVM Participates in PEW Initiative Meeting on Transgenic Animals [ARCHIVED]
  by Wendelyn Jones Warren, Ph.D.
• CVM Issues Draft Guidance on Raw Meat Diets [ARCHIVED]
  by Linda Grassie
• Consent Decree Signed [ARCHIVED]
• Jerome G Woyshner Selected as Chairman of the CVM Field Committee [ARCHIVED]
• Regulatory Activities - January/February 2003 [ARCHIVED]
  by Karen A. Kandra
• FDA Revises Definition of the Term "No Residue" [ARCHIVED]
• CVM Comings and Goings - Volume XVIII, No 1 [ARCHIVED]
• Scientists Gather for NARMS Scientific Meeting [ARCHIVED]
  by Joanne M. Kla, Marcia L. Headrick, D.V.M., M.P.H. and Paula J. Fedorka-Cray, Ph.D.
• Register Now for the FDA Science Forum [ARCHIVED]
• International Activities - Visitors from Hebei and Jiangxi Provinces in the People's Republic of China [ARCHIVED]
• CVM Scientists Help Resolve Russia-U.S. Trade Dispute on Poultry [ARCHIVED]
  by Steven D. Brynes, Ph.D. and Nicholas E. Weber, Ph.D.
• NEW ANIMAL DRUG APPROVALS - January/February 2003 [ARCHIVED]
• SUPPLEMENTAL NEW ANIMAL DRUG APPROVALS - January/February 2003 [ARCHIVED]
• ABBREVIATED NEW ANIMAL DRUG APPROVALS - January/February 2003 [ARCHIVED]
• SUPPLEMENTAL ABBREVIATED NEW ANIMAL DRUG APPROVALS - January/February 2003 [ARCHIVED]